Cargando…

Optimal Follow-up of Patients with Viral Hepatitis Improves the Detection of Early-stage Hepatocellular Carcinoma and the Prognosis of Survival

Objective To manage patients with viral hepatitis, it is important to screen for hepatitis, conduct a comprehensive examination if such screening is positive, administer antiviral treatment, and conduct surveillance for hepatocellular carcinoma (HCC). The proper execution of this strategy is expecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oeda, Satoshi, Iwane, Shinji, Takasaki, Mitsuhiro, Furukawa, Naoko E, Otsuka, Taiga, Eguchi, Yuichiro, Anzai, Keizo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088533/ https://www.ncbi.nlm.nih.gov/pubmed/27725532

Ejemplares similares

Reducing the mortality rate of hepatitis and liver cancer in Japan
por: Iwane, Shinji, et al.
Publicado: (2017)

Chronic Hepatitis C Treatment with Daclatasvir Plus Asunaprevir Does Not Lead to a Decreased Quality of Life
por: Kawakubo, Megumi, et al.
Publicado: (2018)

Generation Gap for Screening and Treatment of Hepatitis C Virus in Saga Prefecture, Japan: An Administrative Database Study of 35,625 Subjects
por: Isoda, Hiroshi, et al.
Publicado: (2019)

Recommendations from primary care physicians, family, friends and work colleagues influence patients' decisions related to hepatitis screening, medical examinations and antiviral treatment
por: Okada, Michiaki, et al.
Publicado: (2020)

Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis
por: Oeda, Satoshi, et al.
Publicado: (2012)

Categorization and Characterization of Activities Designed to Help Health-care Professionals Involved in Hepatitis Care Increase Their Awareness of the Disease: The Classification of Hepatitis Medical Care Coordinators
por: Kanzaki, Naruyo, et al.
Publicado: (2019)

Regulation of interferon signaling and HCV-RNA replication by extracellular matrix
por: Kuwashiro, Takuya, et al.
Publicado: (2018)

Management of Hepatitis B Surface Antigen and Hepatitis C Antibody-Positive Patients by Departments Not Specializing in Hepatology at a Suburban University Hospital in Japan: A Single-Center Observational Study
por: Tokushima, Yoshinori, et al.
Publicado: (2020)

Evaluation narcotic analgesic use and survival time in terminal stage liver diseases compared with lung cancer: a retrospective chart review
por: Nakashita, Shunya, et al.
Publicado: (2013)

Assessment of tumor volume and density as a measure of the response of advanced hepatocellular carcinoma to sorafenib: Application of automated measurements on computed tomography scans
por: Yamamichi, Junta, et al.
Publicado: (2019)

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
por: Otsuka, Taiga, et al.
Publicado: (2015)

Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis
por: Kojima, Motoyasu, et al.
Publicado: (2020)

Entecavir administration to pregnant Japanese woman with chronic hepatitis B and hepatocellular carcinoma: A case report
por: Kakiuchi, Toshihiko, et al.
Publicado: (2021)

Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLD
por: Takahashi, Hirokazu, et al.
Publicado: (2021)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
por: Murayama, Kenichiro, et al.
Publicado: (2021)

What Can Be Done to Address the Exhaustive Referral of Patients with Viral Hepatitis to Specialists?
por: Takahashi, Hirokazu, et al.
Publicado: (2020)

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis
por: Isoda, Hiroshi, et al.
Publicado: (2017)

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis
por: Isoda, Hiroshi, et al.
Publicado: (2017)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Reply to the Letter to the editor “Ipragliflozin improves the hepatic outcomes of patients with diabetes with NAFLD”
por: Takahashi, Hirokazu, et al.
Publicado: (2022)

Influence of muscle fiber type composition on early fat accumulation under high-fat diet challenge
por: Hua, Ning, et al.
Publicado: (2017)

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
por: Takahashi, Hirokazu, et al.
Publicado: (2018)

Discordant pathological diagnosis of non‐alcoholic fatty liver disease: A prospective multicenter study
por: Kuwashiro, Takuya, et al.
Publicado: (2019)

Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005)

The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
por: Nakano, Masahito, et al.
Publicado: (2019)

Baseline C-Reactive Protein Levels and Life Prognosis in Parkinson Disease
por: Sawada, Hideyuki, et al.
Publicado: (2015)

Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease
por: Umemura, Atsushi, et al.
Publicado: (2015)

Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients
por: Araki, Norimasa, et al.
Publicado: (2020)

An incidental latent adult hemophilia case found after a tonsillectomy
por: Saikawa, Yuichiro, et al.
Publicado: (2021)

Clinical manifestation, staging and prognosis of hepatocellular carcinoma in Gambian patients
por: Bittaye, Sheikh Omar, et al.
Publicado: (2023)

Mechanisms of PKC-Mediated Enhancement of HIF-1α Activity and its Inhibition by Vitamin K2 in Hepatocellular Carcinoma Cells
por: Xia, Jinghe, et al.
Publicado: (2019)

Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia
por: Baatarkhuu, Oidov, et al.
Publicado: (2018)

Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
por: Zhou, Yanming, et al.
Publicado: (2011)

Comparative Study of Hepatocellular Carcinoma in Shikoku, Japan: a Study of 198 Autopsy Cases in Tokushima and Ehime Prefectures
por: Akagi, Go, et al.
Publicado: (1988)

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma: Prediction of stage I HCC prognosis
por: Li, Zhiqiang, et al.
Publicado: (2022)

Viral elimination is essential for improving surgical outcomes of hepatitis C virus‐related hepatocellular carcinoma: Multicenter retrospective analysis
por: Nakajima, Masao, et al.
Publicado: (2020)

The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE
por: Kimura, Yusuke, et al.
Publicado: (2020)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Datfar, Toofan, et al.
Publicado: (2021)

Editorial: Diagnosis, Treatment, and Prognosis of Viral Hepatitis
por: Wu, Jian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0hfi2qj5r6sagsft3cnl48ftvq